Smith & Nephew reported first-quarter revenue of $1.39bn in an update on Wednesday, up 2.9% year-on-year, as its orthopaedics business continued to recover.
UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.
AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.